Cerenome, Inc. short interest in 2025
In 2025, Cerenome, Inc.'s disclosed short interest ran from 1.72% of shares outstanding on 15 Jan 2025 to 5.34% on 31 Dec 2025, a change of +3.62 percentage points. The year's high was 20.53% on 15 May 2025 and its low 1.01% on 14 Feb 2025, averaging 5.27% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.11 days on 31 Jan 2025. Full history: Cerenome, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 1.72% (15 Jan 2025)
- End of year
- 5.34% (31 Dec 2025)
- Change
- +3.62 pp
- High
- 20.53% (15 May 2025)
- Low
- 1.01% (14 Feb 2025)
- Average
- 5.27%
- Highest days to cover
- 7.11 (31 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 1.72% | 2.81 | |
| 31 Jan 2025 | 1.50% | 7.11 | |
| 14 Feb 2025 | 1.01% | 2.18 | |
| 28 Feb 2025 | 2.38% | 1.00 | |
| 31 Mar 2025 | 7.36% | 1.00 | results (8-K), 10-K filed |
| 15 Apr 2025 | 6.64% | 1.00 | |
| 30 Apr 2025 | 12.25% | 1.00 | |
| 15 May 2025 | 20.53% | 1.77 | |
| 30 May 2025 | 1.57% | 1.00 | 10-Q filed, results (8-K) |
| 13 Jun 2025 | 3.56% | 1.00 | |
| 31 Jul 2025 | 5.69% | 1.00 | |
| 15 Aug 2025 | 3.15% | 1.00 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 4.70% | 1.00 | |
| 15 Sep 2025 | 4.10% | 1.00 | |
| 15 Oct 2025 | 1.95% | 1.00 | |
| 31 Oct 2025 | 5.73% | 1.00 | 10-Q filed, results (8-K) |
| 14 Nov 2025 | 5.66% | 2.01 | |
| 28 Nov 2025 | 5.38% | 1.02 | |
| 15 Dec 2025 | 5.15% | 1.28 | |
| 31 Dec 2025 | 5.34% | 2.10 |
See also: Cerenome, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.